[1]曹 云a,张晓艳a,曹德勇,等.凝血五项质控血浆低温冷冻后复融方式对其稳定性的影响[J].现代检验医学杂志,2017,32(01):128-130.[doi:10.3969/j.issn.1671-7414.2017.01.035]
 CAO Yuna,ZHANG Xiao-yana,CAO De-yong,et al.Thawing Modes on Stability of Coagulation Control Products afterFrozen[J].Journal of Modern Laboratory Medicine,2017,32(01):128-130.[doi:10.3969/j.issn.1671-7414.2017.01.035]
点击复制

凝血五项质控血浆低温冷冻后复融方式对其稳定性的影响()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第32卷
期数:
2017年01期
页码:
128-130
栏目:
研究简报·实验技术
出版日期:
2017-01-25

文章信息/Info

Title:
Thawing Modes on Stability of Coagulation Control Products afterFrozen
文章编号:
1671-7414(2017)01-128-03
作者:
曹 云1a张晓艳1a曹德勇2张 瑞3辛田田1b
1.延安市人民医院a.检验科;
b.重症医学科,陕西延安 716000;
2.延安大学附属医院东关分院心血管内科,陕西延安 716000;
3.延安大学附属医院检验科,陕西延安 716000
Author(s):
CAO Yun1aZHANG Xiao-yan1aCAO De-yong2ZHANG Rui3XIN Tian-tian1b
1a.Department of Clinical Laboratory;
1b.Department ofICU,the People's Hospital of Yan'an, Shaanxi Yan'an 716000,China;
2.Department of Cardiovascular,Dongguan Branch of Yan'an University Hospital,Shaanxi Yan'an 716000,China;
3.Departmentof Cl
关键词:
凝血质控物 复融 稳定性
分类号:
R446.111
DOI:
10.3969/j.issn.1671-7414.2017.01.035
文献标志码:
A
摘要:
目的 探讨凝血五项质控血浆低温冷冻后复融方式对其稳定性的影响,为实验室成本控制寻找新的理论依据。方法 采用美国IL公司ACL TOP700全自动血凝分析仪及其配套同批号试剂和质控品进行该项研究:常规做完质控后,立即将剩余质控品分装到2个EP管中并冻存于-40℃,24 h后通过室温放置30 min和37℃水浴快速两种方式复融,并随当日质控物一起进行检测,连续收集20组数据分析两种复融方式对凝血系列质控品质控参数稳定性的影响。结果 室温复融组复融后测定的APTT,PT中值和高值,FIB中值,D-Dimer高值复融前后差异均无统计学意义(P>0.05); 而FIB高值平均升高0.23 g/L(t=4.0269,P<0.05); TT中值平均缩短0.46 s(t=-3.813 8,P<0.05),TT高值平均缩短0.41s(t=-3.972 8,P<0.05); D-Dimer低值平均增加14.75 ng/ml FEU(t=2.281 6,P<0.05)。37℃水浴快速复融组复融后测定的APTT,PT,FIB,TT,D-Dimer两个水平差异均无统计学意义(P>0.05)。结论 商用凝血质控品短期冻融后只要遵循快速复融原则并及时检测,是可以作为二次质控物来应用,其他实验室可作为参考。
Abstract:
Objective To investigate the thawing modes on stability of coagulation control products after frozen,looking for a new theoretical basis for cost control and the quality and safety of laboratory.Methods Using ACL TOP 700 automated coagulation analyzer and supporting the same batch of reagents and quality control materials conduct of the study:after daily QC,recycled the remaining control materials immediately and dispensed into two EP tubes and frozen at -40℃,respectively thawed by room-temperature and 37℃water bath after 24 hours, and examined together with the dateof quality control material,got 20 pairs of data for analysis the financial impact of two alternate ways on coagulation QC parameters.Results For the room-temperature thawing group,FIB high value increasedby an average 0.23 g/L(t=4.026 9,P<0.05); TT normal value average reduction of 0.46 s(t=-3.813 8,P<0.05),TT high value reduced by an average 0.41s(t=-3.972 8,P<0.05); D-Dimer low-value increased by an average of 14.75 ng/ml FEU(t=2.281 6,P<0.05),while APTT,PT normal and high value,FIB normal value,D-Dimer high value were no significant difference after thawing(P>0.05).For the 37℃ water bath group,both normal and high valueof APTT,PT,FIB,TT and D-Dimer were no significant difference after thawing(P>0.05).Conclusion The commercialization of coagulation control materials can be for the second QC,just follow the principle of rapid after melting and timely detection,other laboratories can be used as a reference.

参考文献/References:

[1] 朱忠勇.凝血酶原时间和活化部分凝血活酶时间测定标准化[J].中华医学检验杂志,1998,21(5):308-312. Zhu ZY.Standardization of prothrombin time and activated partial thrombin time determination[J].Chinese Journal of Medical Laboratory Sciences,1998,21(5):308-312.
[2] 丛玉隆.积极开展血栓与止血实验及质量控制[J].中华医学检验杂志,1998,21(5):261-262. Cong YL.Actively developing thrombosis and hemostasis testing and quality control[J].Chinese Journal of Medical Laboratory Sciences,1998,21(5):261-262.
[3] 中华人民共和国卫生部.卫生部关于印发《医疗机构临床实验室管理办法》的通知.2006. People's Republic of China Ministry of Health.Ministry of Health on the issuance of “medical institutions,clinical laboratory management approach”.2006.
[4] 况妮娜.凝血质控品复溶后稳定性研究[J].安徽医学,2012,33(7):897-898. Kuang NN.Stability of coagulation quality control materials after reconstitution[J].Anhui Medicine Journal,2012,33(7):897-898.
[5] 华丽姿.自制凝血质控物稳定性及复融方式探讨[J].检验医学与临床,2013,10(10):1299-1301. Hua LZ.Discussion on the stability and thawing mode of homemade coagulation quality control[J].Laboratory Medicine and Clinical,2013,10(10):1299-1301.
[6] 苍金荣,王 华,任建康.凝血/止血检测的质量保证[J].现代检验医学杂志,2003,18(6):45-46. Cang JR,Wang H,Ren JK.Quality assurance of coagulation and hemostasis testing[J].Journal of Modern Laboratory Medicine,2003,18(6):45-46.
[7] 李曼辉,杨宇勤,姚元超.健康者混合血浆制备凝血质控物及其稳定性的探讨[J].国际检验医学杂志,2011,32(7):809-810. Li MH,Yang YQ,Yao YC.Explore the stability of coagulation controlplasma prepared from healthy mix[J].International Journal of Laboratory Medicine,2011,32(7):809-810.
[8] Zhao Y,L(¨overu)G.Influence of temperature and storage duration on measurement of activated partial thromboplastin time,D-dimers,fibrinogen,prothrombin time and thrombin time,in citrate-anticoagulated whole blood speciments[J].Int J Lab Hematol,2013,35(5):566-570.
[9] Feng L,Zhao Y,Zhao H,et al.Effects of storage time and temperature oncoagulation tests and factors in fresh plasma[J].Sci Rep,2014(4):3868.
[10] Mohammed Saqhir SA,Al-Hassan FM,Alsalahi OS,et al.Optimization of the storage conditions for coagulation screening tests[J].J Coll Physicians Surq Pak,2012,22(5):294-297.
[11] 常 萍,史清海,刁 彤,等.凝血5项试验室内质控血浆的制备及应用评价[J].检验医学与临床,2012,9(11):1357-1358. Chang P,Shi QH,Diao T,et al.Preparation and evaluation of coagulationfive internal quality control test plasma[J].Laboratory Medicine and Clinical,2012,9(11):1357-1358.
[12] 平竹仙,孙 武,蒋红君,等.自制凝血室内质控品的使用与评估[J].国际检验医学杂志,2014,35(20):2841-2842. Ping ZX,Sun W,Jiang HJ,et al.Use and evaluation of homemade clotting internal quality control products[J].International Journal of Laboratory Medicine,2014,35(20):2841-2842.
[13] 叶 健.自制凝血质控品的应用及评价[J].医学检验与临床,2015,26(5):77,79. Ye J.Application and evaluation of self-coagulation control materials[J].Medical Laboratory Science and Clinical,2015,26(5):77,79.
[14] 冯仁丰.临床检验质量管理技术基础[M].上海:上海科学技术文献出版社,2003:155-156. Feng RF.Basis for clinical laboratory quality management techniques[M].Shanghai:Shanghai Science and Technology Literature Press,2003:155-156.

备注/Memo

备注/Memo:
基金项目:延安市科技惠民专项(2015HM-16)。
作者简介:曹 云(1964-),女,本科,主任检验师,研究方向:主要从事临床检验及质量控制方面的研究。
通讯作者:辛田田,主治医师,研究方向:重症患者凝血稳态变化机制,E-mail:yananznfe@126.com。
更新日期/Last Update: 2017-01-20